(18)F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy

The ability to assess the distribution and extent of tau pathology in Alzheimer’s disease and progressive supranuclear palsy in vivo would help to develop biomarkers for these tauopathies and clinical trials of disease-modifying therapies. New radioligands for positron emission tomography have gener...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain
Main Authors: Passamonti, Luca, Vázquez Rodríguez, Patricia, Hong, Young T., Allinson, Kieren S. J., Williamson, David, Borchert, Robin J., Sami, Saber, Cope, Thomas E., Bevan-Jones, W. Richard, Jones, P. Simon, Arnold, Robert, Surendranathan, Ajenthan, Mak, Elijah, Su, Li, Fryer, Tim D., Aigbirhio, Franklin I., O’Brien, John T., Rowe, James B.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382948/
https://ncbi.nlm.nih.gov/pubmed/28122879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/aww340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados